Physician profile
Adam Devine
NPI 1043839251
$923.84
in general payments reported to CMS, 2019-2025
13 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.36 · 2021: $19.18 · 2022: $58.25 · 2023: $250 · 2024: $149 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.91 | 2024-2025 | Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.84 | 2025 | Ofev |
| Nestle Healthcare Nutrition INC. | $125.00 | 2023 | |
| Glaxosmithkline, LLC. | $124.99 | 2023 | |
| Verona Pharma, INC. | $116.99 | 2025 | Ohtuvayre |
| Genzyme Corporation | $66.13 | 2024 | |
| Inari Medical, INC. | $58.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $24.38 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Amgen INC. | $20.84 | 2022 | |
| Acadia Pharmaceuticals INC | $19.77 | 2022 | |
| Teleflex LLC | $19.18 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.36 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.